Showing results 21 to 40 of 83
< previous
next >
| Issue Date | Title | Author(s) |
| 2021-02 | Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities. | Lee, L-Y; Hew, GSY; Meenu,; Shukla, SD; Satija, S; Khurana, N; Anand, K; Dureja, H; Singh, SK; Mishra, V; Singh, PK; Gulati, M; Prasher, P; Aljabali, AAA; Tambuwala, MM; Thangavelu, L; Panneerselvam, J; Gupta, G; Zacconi, FC; Shastri, M; Jha, NK; Xenaki, D; MacLoughlin, R; Oliver, BG; Chellappan, DK; Dua, K |
| 2021-01-01 | Introduction to cancer cell biology | Shaikh, MA; Gilhotra, R; Singh, SK; Rawat, S; Gupta, G; Hussain, S; Singh, Y; Satija, S; Mehta, M; Dua, K |
| 2021-01-01 | Chapter 1 Introduction to cancer cell biology | Shaikh, MA; Hussain, S; Gilhotra, R; Singh, SK; Rawat, S; Singh, Y; Satija, S; Mehta, M; Dua, K; Gupta, G |
| 2021-01-01 | Chapter 15 Novel Controlled Release Pulmonary Drug Delivery Systems: Current updates and Challenges | Dhanjal, DS; Mehta, M; Chopra, C; Singh, R; Sharma, P; Chellappan, DK; Tambuwala, MM; Bakshi, HA; Aljabali, AAA; Gupta, G; Nammi, S; Prasher, P; Dua, K; Satija, S |
| 2021-01-01 | Nanosuspensions - An Update on Recent Patents, Methods of Preparation, and Evaluation Parameters. | Khanuja, HK; Awasthi, R; Mehta, M; Satija, S; Aljabali, AA; Tambuwala, MM; Chellappan, DK; Dua, K; Dureja, H |
| 2021-01-01 | Chapter 35 Targeting siRNAs in cancer drug delivery | Obeid, MA; Aljabali, AAA; Alshaer, W; Charbe, NB; Chellappan, DK; Dua, K; Satija, S; Tambuwala, MM |
| 2021 | Perfluorocarbons Therapeutics in Modern Cancer Nanotechnology for Hypoxiainduced Anti-tumor Therapy. | Satija, S; Sharma, P; Kaur, H; Dhanjal, DS; Chopra, RS; Khurana, N; Vyas, M; Sharma, N; Tambuwala, MM; Bakshi, HA; Charbe, NB; Zacconi, FC; Chellappan, DK; Dua, K; Mehta, M |
| 2021 | Hypoxia-Inducible Factor (HIF): Fuel for Cancer Progression. | Satija, S; Kaur, H; Tambuwala, MM; Sharma, P; Vyas, M; Khurana, N; Sharma, N; Bakshi, HA; Charbe, NB; Zacconi, FC; Aljabali, AA; Nammi, S; Dureja, H; Singh, TG; Gupta, G; Dhanjal, DS; Dua, K; Chellappan, DK; Mehta, M |
| 2020-12-01 | Overcoming the dissolution rate, gastrointestinal permeability and oral bioavailability of glimepiride and simvastatin co-delivered in the form of nanosuspension and solid self-nanoemulsifying drug delivery system: A comparative study | Pandey, NK; Singh, SK; Gulati, M; Kumar, B; Kapoor, B; Ghosh, D; Kumar, R; Khursheed, R; Awasthi, A; Kuppusamy, G; Wadhwa, S; Satija, S; Dureja, H; Jain, SK; Chellappan, DK; Anand, K; Mehta, M; Dua, K |
| 2020-12-01 | Development of modified apple polysaccharide capped silver nanoparticles loaded with mesalamine for effective treatment of ulcerative colitis | Kaur, G; Singh, SK; Kumar, R; Kumar, B; Kumari, Y; Gulati, M; Pandey, NK; Gowthamarajan, K; Ghosh, D; Clarisse, A; Wadhwa, S; Mehta, M; Satija, S; Dua, K; Dureja, H; Gupta, S; Singh, PK; Kapoor, B; Chitranshi, N; Kumar, A; Porwal, O |
| 2020-11-30 | Correction: Aljabali, A.A.A.; et al. Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer via down Regulation of Nuclear p65 and HIF-1α. Cancers 2020, 12, 113. | Aljabali, AAA; Bakshi, HA; Hakkim, FL; Haggag, YA; Al-Batanyeh, KM; Zoubi, MSA; Al-Trad, B; Nasef, MM; Satija, S; Mehta, M; Pabreja, K; Mishra, V; Khan, M; Abobaker, S; Azzouz, IM; Dureja, H; Pabari, RM; Dardouri, AAK; Kesharwani, P; Gupta, G; Dhar Shukla, S; Prasher, P; Charbe, NB; Negi, P; Kapoor, DN; Chellappan, DK; Webba da Silva, M; Thompson, P; Dua, K; McCarron, P; Tambuwala, MM |
| 2020-11-16 | Advancing of Cellular Signaling Pathways in Respiratory Diseases Using Nanocarrier based Drug Delivery Systems. | Mehta, M; Dhanjal, DS; Satija, S; Wadhwa, R; Paudel, KR; Chellappan, DK; Mohammad, S; Haghi, M; Hansbro, PM; Dua, K |
| 2020-11-06 | Potential Anti-epileptic Phytoconstituents: An Updated Review. | Kaur, J; Famta, P; Famta, M; Mehta, M; Satija, S; Sharma, N; Vyas, M; Khatik, GL; Chellappan, DK; Dua, K; Khurana, N |
| 2020-11-04 | Interferon therapy for preventing COPD exacerbations | Mehta, M; Paudel, KR; Shukla, SD; Shastri, M; Singh, SK; Gulati, M; Dureja, H; Gupta, G; Satija, S; Hansbro, PM; Chellappan, DK; Dua, K |
| 2020-11 | Beta-catenin non-canonical pathway: A potential target for inflammatory and hyperproliferative state via expression of transglutaminase 2 in psoriatic skin keratinocyte. | Gupta, G; Singh, Y; Tiwari, J; Raizaday, A; Alharbi, KS; Al-Abbasi, FA; Kazmi, I; Satija, S; Tambuwala, MM; Devkota, HP; Krishnan, A; Chellappan, DK; Dua, K |
| 2020-11 | Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis | Mehta, M; Prasher, P; Sharma, M; Shastri, MD; Khurana, N; Vyas, M; Dureja, H; Gupta, G; Anand, K; Satija, S; Chellappan, DK; Dua, K |
| 2020-10-30 | Antiproliferative effects of boswellic acids-loaded chitosan nanoparticles on human lung cancer cell line A549. | Solanki, N; Mehta, M; Chellappan, DK; Gupta, G; Hansbro, NG; Tambuwala, MM; Aa Aljabali, A; Paudel, KR; Liu, G; Satija, S; Hansbro, PM; Dua, K; Dureja, H |
| 2020-10-05 | Targeting interleukins in chronic airway diseases using advanced drug delivery. | Satija, S; Mehta, M; Gupta, G; Chellappan, DK; Dua, K |
| 2020-09-24 | Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives. | Mehta, M; Satija, S; Paudel, KR; Malyla, V; Kannaujiya, VK; Chellappan, DK; Bebawy, M; Hansbro, PM; Wich, PR; Dua, K |
| 2020-09-01 | Emerging trends of liquid crystalline nanoparticles drug delivery for pulmonary disorders | Singh, VP; Mehta, M; Satija, S; Sharma, DS; Sharma, PK |
